The international surgical journal with global reach

This is the Scientific Surgery Archive, which contains all randomized clinical trials in surgery that have been identified by searching the top 50 English language medical journal issues since January 1998. Compiled by Jonothan J. Earnshaw, former Editor-in-Chief, BJS

Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial. Lancet Gastroenterol Hepatol 2020; 5: 548-560.

Published: 17th November 2020

Authors: Li J, Xing J, Yang Y, Liu J, Wang W, Xia Y et al.

Conclusion

Some 156 patients were included. After median follow-up of 55.9 months, relapse-free survival was 43.4 per cent after active treatment versus 21.7 per cent in controls (hazard ratio 0.49, 95 per cent confidence interval 0.34 to 0.72, P=0.0031).

Pubmed Link